MedTrace Logo

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

NCT00079638 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2006-11-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of first-line treatment using Niaspan (an extended release version of niacin) and statins versus other drugs that lower lipid levels, in subjects with elevated fat levels in their blood (dyslipidemia). Statins are a class of medication that is often prescribed to patients who need to lower their cholesterol levels.

Conditions

Interventions

DRUG

Niacin

DRUG

Atorvastatin

DRUG

Simvastatin

DRUG

Ezetimibe

DRUG

Rosuvastatin

Sponsors & Collaborators

  • Kos Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • COMPELL TEAM · Contact COMPELL Team Member (800) 722-4567

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2005-05-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00079638 on ClinicalTrials.gov